Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Zeitlin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|September 5, 2006
Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2Benjamin D Zeitlin, Esther Joo, Zhihong Dong, et al.
Translational Oncology|December 2, 2008
Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial CellsAaron C Spalding, Benjamin D Zeitlin, Kari Wilder-Romans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiationBenjamin D Zeitlin, Aaron C Spalding, Marcia S Campos, et al.
Cancer Research|December 14, 2011
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsAtsushi Imai, Benjamin D Zeitlin, Fernanda Visioli, et al.
Molecular Cancer Therapeutics|April 18, 2009
TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesisNaoki Ashimori, Benjamin D Zeitlin, Zhaocheng Zhang, et al.
Journal of Endodontics|October 19, 2010
Effects of morphogen and scaffold porogen on the differentiation of dental pulp stem cellsFlavio F Demarco, Luciano Casagrande, Zhaocheng Zhang, et al.
Experimental Cell Research|August 28, 2007
Level of endothelial cell apoptosis required for a significant decrease in microvessel densityZhihong Dong, Benjamin D Zeitlin, Wenying Song, et al.
Blood|August 28, 2009
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesisRobert C Doebele, Frank T Schulze-Hoepfner, Jia Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2010
From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathwayRicardo J Giordano, Marina Cardó-Vila, Ahmad Salameh, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|September 5, 2006
Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2Benjamin D Zeitlin, Esther Joo, Zhihong Dong, et al.
Translational Oncology|December 2, 2008
Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial CellsAaron C Spalding, Benjamin D Zeitlin, Kari Wilder-Romans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiationBenjamin D Zeitlin, Aaron C Spalding, Marcia S Campos, et al.
Cancer Research|December 14, 2011
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsAtsushi Imai, Benjamin D Zeitlin, Fernanda Visioli, et al.
Molecular Cancer Therapeutics|April 18, 2009
TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesisNaoki Ashimori, Benjamin D Zeitlin, Zhaocheng Zhang, et al.
Journal of Endodontics|October 19, 2010
Effects of morphogen and scaffold porogen on the differentiation of dental pulp stem cellsFlavio F Demarco, Luciano Casagrande, Zhaocheng Zhang, et al.
Experimental Cell Research|August 28, 2007
Level of endothelial cell apoptosis required for a significant decrease in microvessel densityZhihong Dong, Benjamin D Zeitlin, Wenying Song, et al.
Blood|August 28, 2009
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesisRobert C Doebele, Frank T Schulze-Hoepfner, Jia Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2010
From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathwayRicardo J Giordano, Marina Cardó-Vila, Ahmad Salameh, et al.
Pageof 2